This is the first in situ hybridization analysis of expression of a tumor necrosis factor (TNF) receptor associated factor (TRAF) during development. TRAF4 is observed throughout mouse embryogenesis, most notably during ontogenesis of the central (CNS) and peripheral (PNS) nervous system, and of nervous tissues of sensory organs. TRAF4 is preferentially expressed by post-mitotic undifferentiated neurons. Interestingly, TRAF4 remains expressed in the adult hippocampus and olfactory bulb, known to contain multipotential cells responsible for neoneurogenesis.
Introduction
Tumor necrosis factors (TNFs) are mediators of inflammatory and immune processes, and exhibit cytotoxic properties on malignant cells. TNFs act via specific receptors (TNF-Rs) devoid of intrinsic catalytic activity. Thus, intracellular factors are required to transmit the signal to the cell nucleus, and several of them belong to the TNF-R associated factor (TRAF) family (reviewed in Vandenabeele et al., 1995; Aggarwal and Natarajan, 1996; Baker and Reddy, 1996) . A similar function in the TNF signaling pathway is expected for TRAF4 (previously named CART1) . Moreover, since TRAF4 possesses nuclear localization signal (NLS), it might be a latent cytoplasmic transcriptional factor. Ectopic TRAF4 expression occurs in 20% of human breast carcinomas, suggesting that it could be involved in malignant process(es) (Bièche et al., 1996) .
To date, few data concerning the embryonic expression of molecules involved in the TNF signaling pathways have been reported. TNF is preferentially expressed during early stages of development where apoptotic events occur and has been proposed to play a major role during embryogenesis (Wride and Sanders, 1993) . More recently, Fas and FasL were shown to be expressed from 16.5 days post-coitum (dpc) onwards until birth (French et al., 1996) , and TRAF3 during early and late stages of post-implantation development (Wang et al., 1996) . In the present study, we have investigated TRAF4 expression during mouse development. (Fig. 1) and containing an amino-terminal C3HC3D RING, three C3HC3H CART, a carboxy-terminal TRAF and two NLS domains. Moreover, there is a syntenic linkage conservation for the mouse and human TRAF4 genes, since they are localized to the 11B5-11C (data not shown) and 17q11-q12 regions, respectively.
Cloning and characterization of mouse TRAF4 cDNA

TRAF4 is expressed throughout embryogenesis
Northern blot analysis showed that TRAF4 is strongly expressed throughout embryogenesis with a maximum from 8.5 to 13.5 days post-coitum (dpc) (Fig. 2) . TRAF2 and TRAF3, but not TRAF1, were consecutively expressed.
TRAF4 is strongly expressed during neurogenesis
At 8.5-10.5 dpc, TRAF4 is expressed in the neuroepithelium (Fig. 3A) and its derivatives including trigeminal and facio-acoustic neural crest cell (NCC) condensations, and first, second and third NCC-colonized branchial arches (Fig.  3C ). In addition, limb buds express TRAF4 (Fig. 3C ). At 12.5 dpc TRAF4 expression extends to the brain, spinal cord, and facial and dorsal root ganglia (Fig. 3E) , and to the neuroretina. At 14.5 dpc, high expression levels are detected in the neuroepithelium of the nasal fossae (Fig.  3F ) and, at 16.5 dpc, in thymus, salivary glands and intestine (Fig. 3G) . Thus, throughout embryogenesis, TRAF4 expression occurs in various organs, especially during the development of the CNS and PNS, and sensory organs.
TRAF4 is preferentially expressed by post-mitotic undifferentiated neurons
In the cephalic vesicle walls (Fig. 3E, 4A ,F) and spinal cord (Fig. 4B,G) , TRAF4 transcripts were observed in neurons of the mantle layer (Fig. 4A,B ) which corresponds to a transitional zone containing migrating and differentiating post-mitotic neurons (Rugh, 1968; Kaufman, 1992) . In a similar manner, in the retina, TRAF4 is preferentially observed in an intermediate region encompassing part of the outer and inner zones (Fig. 4D,I ) known to contain proliferating neuroblasts and differentiated sensory neurons, respectively (Wheater et al., 1987) . These findings suggest that neurons expressing TRAF4 were post-mitotic and undifferentiated. In order to test this hypothesis, we have performed BrdU and class III b-tubulin analysis, since they are markers of proliferating and differentiated neurons, respectively. As expected, BrdU (Fig. 4A-C) and class III b-tubulin (Fig. 4F-H ) staining did not overlap TRAF4 positive areas.
TRAF4 remains expressed in the adult brain
In the adult CNS, TRAF4 remains expressed in the hippocampus (Fig. 4E) , notably in the dentate gyrus and CA1 regions, and in the olfactory bulb. A sharp TRAF4 expression is also observed in the Purkinje cells of the cerebellum (Fig. 4J,K) . Interestingly, the hippocampus and olfactory bulb are known to contain post-mitotic undifferentiated neurons able to later differentiate during neoneurogenesis (Alvarez-Buylla and Lois, 1995; McKay, 1997) . By contrast, expression of TRAF4 has completely disappeared from the adult neuroretina (data not shown) whose neurons are completely differentiated (Rugh, 1968; Wheater et al., 1987) . Interestingly, a neuroprotective role has been recently proposed for TNF since brain injuries in mice lacking both TNF-RI and TNF-RII lead to increased neuronal cell degeneration (Bruce et al., 1996) .
Previous studies have implicated TRAFs in a number of cellular responses in lymphoid cells (reviewed in Vandenabeele et al., 1995; Aggarwal and Natarajan, 1996; Baker and Reddy, 1996) . Accordingly, TRAF4 was expressed in organs of the hematopoietic system. However, our findings show that TRAF4 is also highly expressed during neurogenesis. Several links exist between the neuro-and hematopoietic systems, and it is noteworthy that TNF is actually synthesized and secreted in both systems (Bazan, 1991; Reichlin, 1993) .
Methods
Cloning of the mouse TRAF4 cDNA
ES lambda ZAPII oligodT cDNA library (J.M. Garnier, IGBMC) was screened as in Tomasetto et al. (1995) using a 32 P-labeled human TRAF4 cDNA . dsDNA was sequenced with Taq polymerase, using universal and internal primers.
Chromosomal assignment was carried out by in situ hybridization on chromosome preparations from phytohemagglutinin-stimulated lymphocytes , using a 3 H-labeled probe containing 1100 bp TRAF4 cDNA and pBluescript.
Embryo and tissue collections
Embryos and tissues were either collected in cold PBS (whole mount in situ hybridization), liquid nitrogen (RNA extraction), or embedded in Tissue-Tek OCT compound (Miles Diagnostic Division, Elkhart, IN) and frozen in an ethanol/solid CO 2 bath (in situ hybridization), or fixed in phosphate buffered formalin (4%) and embedded in gelatine/sucrose (immunohistochemistry).
Northern blot analysis
RNA was prepared using acid guanidinium thiocyanate (Chomczynski and Sacchi, 1987) , electrophoresed in 1% agarose gels containing formaldehyde and transferred to membranes (hybond N, Amersham). Blots were hybridized as in Régnier et al. (1995) using the 32 P-labeled TRAF1 (L35302, nucleotides 230-1456), TRAF2 (L35303, nucleotides 51-1553), TRAF3 (L21050, nucleotides 1177-1884), recloned by RT-PCR, TRAF4 (nucleotides 515-2003) and 36B4 (Masiakowski et al., 1982) probes.
Digoxigenin in situ hybridization
Whole embryos, proteinase K treated and fixed in glutaraldehyde/formaldehyde, were hybridized using digoxigenin-labeled (Boehringer Mannheim) sense or antisense TRAF4 cDNA (2003 bp). Hybridization was followed by RNase treatment (0.1 mg/ml, 2 × 30 min, 37°C) and washings (2 × SSC, 50% formamide, 65°C, 2 × 30 min). Detection was performed by using an anti-digoxigenin antibody conjugated with alkalin phosphatase (Boehringer Mannheim).
Tissue sections (14 mm) from embryos fixed in formaldehyde, mounted in gelatin/sucrose and frozen, were hybridized as described by Myat et al. (1996) , using the antibodies reported above.
Radioactive in situ hybridization
Cryosections (6 mm) fixed in acetone and formaldehyde were treated with proteinase K and hybridized with 35 Slabeled sense or antisense TRAF4 riboprobe (nucleotides 1-2015). Hybridization was followed by RNase treatment (20 mg/ml, 30 min, 37°C) and two stringent washings (2× SSC, 50% formamide, 60°C, 2 h), before autoradiography using NTB2 emulsion (Kodak). Autoradiography was for 3 weeks. Sections were counter-stained using toluidine blue.
BrdU and class III b-tubulin immunohistochemistry
Two milligrams of BrdU were injected intraperitoneally into pregnant mice 3 h before they were sacrificed. Embryos were formaldehyde fixed. Sections were first processed for digoxygenin in situ hybridization, and then for immunohistochemistry (Guillemot and Joyner, 1993) using either antiBrdU or anti-class III b-tubulin antibody (Sigma). Revelation was performed using Vectastain kit (Vector).
